Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s traded shares stood at 3.89 million during the last session, with the company’s beta value hitting 1.05. At the close of trading, the stock’s price was $0.09, to imply a decrease of -4.87% or -$0.01 in intraday trading. The CNSP share’s 52-week high remains $23.90, putting it -26455.56% down since that peak but still an impressive 11.11% since price per share fell to its 52-week low of $0.08. The company has a valuation of $5.28M, with an average of 9.78 million shares in intraday trading volume over the past 10 days and average of 15.37 million shares over the past 3 months.

Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information

After registering a -4.87% downside in the last session, Cns Pharmaceuticals Inc (CNSP) has traded red over the past five days. The 5-day price performance for the stock is -8.02%, and -22.73% over 30 days. With these gigs, the year-to-date price performance is -23.75%. Short interest in Cns Pharmaceuticals Inc (NASDAQ:CNSP) saw shorts transact 1.14 million shares and set a 0.04 days time to cover.

The extremes give us $0.5 and $0.5 for target low and target high price respectively. As such, CNSP has been trading -455.56% off suggested target high and -455.56% from its likely low.

CNSP Dividends

Cns Pharmaceuticals Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders

Cns Pharmaceuticals Inc insiders hold 1.04% of total outstanding shares, with institutional holders owning 0.79% of the shares at 0.80% float percentage. In total, 0.79% institutions holds shares in the company.